Tau passive immunization inhibits not only tau but also Aβ pathology

Table 1 Primary antibodies used in this study

Antibody	Type	Specificity	Phosphorylation sites	Source/reference
43D^a	Monoclonal	Tau		Covance (Princeton, NJ, USA)
77E9^a	Monoclonal	Tau		Covance
R134d	Polyclonal	Tau		[77]
GAPDH	Polyclonal	GAPDH		Santa Cruz Biotechnology (Dallas, TX, USA)
pS199	Polyclonal	p-tau	Ser199	Invitrogen (Carlsbad, CA, USA)
AT8	Monoclonal	p-tau	Ser202/Thr205	Thermo Fisher Scientific (Waltham, MA, USA)
pT205	Polyclonal	p-tau	Thr205	Invitrogen
12E8	Monoclonal	p-tau	Ser262/356	Dr. D. Schenk, Elan Pharmaceuticals (South San Francisco, CA, USA)
PHF1	Monoclonal	p-tau	Ser396/404	Dr. P. Davies, Albert Einstein College of Medicine (Bronx, NY, USA)
APP	Polyclonal	APP		Generated in our institute
4G8	Monoclonal	APP/Aβ		BioLegend (San Diego, CA, USA)
Iba1	Polyclonal	Iba1		Abcam (Cambridge, MA, USA)
Iba1	Polyclonal	Iba1 for IHC		Wako Chemicals (Richmond, VA, USA)
C1q	Monoclonal	C1q		Thermo Fisher Scientific
C9	Polyclonal	C9		Thermo Fisher Scientific

Abbreviations: APP Amyloid precursor protein, Aβ Amyloid-β, GAPDH Glyceraldehyde 3-phosphate dehydrogenase, IHC Immunohistochemistry, PHF1 Paired helical filament 1, pS199 Phospho-tau (Ser199), pT205 Phospho-tau (Thr205), p-tau Phosphorylated tau
^aImmunoglobulin G1 kappa light chain

ISSN: 1758-9193